Peter T. Rowley

2.1k total citations
81 papers, 1.6k citations indexed

About

Peter T. Rowley is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Peter T. Rowley has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Hematology and 18 papers in Genetics. Recurrent topics in Peter T. Rowley's work include Hemoglobinopathies and Related Disorders (17 papers), BRCA gene mutations in cancer (12 papers) and Iron Metabolism and Disorders (10 papers). Peter T. Rowley is often cited by papers focused on Hemoglobinopathies and Related Disorders (17 papers), BRCA gene mutations in cancer (12 papers) and Iron Metabolism and Disorders (10 papers). Peter T. Rowley collaborates with scholars based in United States, United Kingdom and India. Peter T. Rowley's co-authors include Barbara A. Kosciolek, Starlene Loader, Gary R. Skuse, Betsy M. Ohlsson‐Wilhelm, Andrew G. Engel, G. MILTON SHY, T Wanko, James F. Leary, Jeffrey C. Levenkron and Barbara Farley and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter T. Rowley

79 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter T. Rowley United States 23 553 366 309 268 241 81 1.6k
Walter W. Noll United States 21 770 1.4× 255 0.7× 146 0.5× 89 0.3× 507 2.1× 43 2.0k
Jan Waldenström Sweden 22 518 0.9× 234 0.6× 290 0.9× 94 0.4× 131 0.5× 57 2.1k
E.B. Robson United Kingdom 23 694 1.3× 125 0.3× 144 0.5× 312 1.2× 499 2.1× 60 1.9k
Janet van Adelsberg United States 26 918 1.7× 155 0.4× 426 1.4× 529 2.0× 585 2.4× 49 2.6k
C Borrone Italy 24 753 1.4× 99 0.3× 109 0.4× 613 2.3× 252 1.0× 86 1.7k
Kenneth S. Zuckerman United States 24 598 1.1× 330 0.9× 469 1.5× 114 0.4× 98 0.4× 67 1.5k
Gábor Kovács Hungary 28 414 0.7× 252 0.7× 221 0.7× 73 0.3× 92 0.4× 128 2.1k
Ishwar C. Verma India 20 625 1.1× 305 0.8× 235 0.8× 155 0.6× 386 1.6× 139 1.7k
Takeshi Taketani Japan 25 1.2k 2.1× 249 0.7× 649 2.1× 148 0.6× 184 0.8× 119 2.1k
Sara Rollinson United Kingdom 13 824 1.5× 165 0.5× 234 0.8× 182 0.7× 129 0.5× 20 1.6k

Countries citing papers authored by Peter T. Rowley

Since Specialization
Citations

This map shows the geographic impact of Peter T. Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Rowley more than expected).

Fields of papers citing papers by Peter T. Rowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter T. Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Rowley. The network helps show where Peter T. Rowley may publish in the future.

Co-authorship network of co-authors of Peter T. Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of Peter T. Rowley. A scholar is included among the top collaborators of Peter T. Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter T. Rowley. Peter T. Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abu‐Amara, Mahmoud, Shi Yu Yang, Alberto Quaglia, et al.. (2011). Role of endothelial nitric oxide synthase in remote ischemic preconditioning of the mouse liver. Liver Transplantation. 17(5). 610–619. 53 indexed citations
2.
Arnold, Georgianne L., et al.. (2005). Cystic Fibrosis Newborn Screening: A Pilot Study to Maximize Carrier Screening. Genetic Testing. 9(3). 255–260. 13 indexed citations
3.
Loader, Starlene, Cleveland G. Shields, & Peter T. Rowley. (2005). Impact of Genetic Counseling and DNA Testing on Individuals with Colorectal Cancer with a Positive Family History: A Population-Based Study. Genetic Testing. 9(4). 313–319. 14 indexed citations
4.
Chen‐Scarabelli, Carol, Siân Hughes, Peter T. Rowley, et al.. (2005). A Case of Fatal Ephedra Intake Associated with Lipofuscin Accumulation, Caspase Activation and Cleavage of Myofibrillary Proteins. European Journal of Heart Failure. 7(5). 927–930. 9 indexed citations
5.
Loader, Starlene, Cleveland G. Shields, & Peter T. Rowley. (2004). Impact of Genetic Testing for Breast–Ovarian Cancer Susceptibility. Genetic Testing. 8(1). 1–12. 28 indexed citations
6.
Rowley, Peter T.. (2004). Screening for an Inherited Susceptibility to Colorectal Cancer. Genetic Testing. 8(4). 421–430. 10 indexed citations
7.
Loader, Starlene, Cleveland G. Shields, Jeffrey C. Levenkron, Richard Fishel, & Peter T. Rowley. (2002). Patient vs. Physician as the Target of Educational Outreach about Screening for an Inherited Susceptibility to Colorectal Cancer. Genetic Testing. 6(4). 281–290. 17 indexed citations
8.
Rowley, Peter T. & Starlene Loader. (2001). Points to Consider in Designing a Clinical Trial to Ascertain the Utility of a Genetic Screening Test. Genetic Testing. 5(3). 219–221. 1 indexed citations
9.
Loader, Starlene & Peter T. Rowley. (1998). Deleterious Mutations of Both BRCA1 and BRCA2 in Three Siblings. Genetic Testing. 2(1). 75–77. 14 indexed citations
10.
Loader, Starlene, Jeffrey C. Levenkron, & Peter T. Rowley. (1998). Genetic Testing for Breast-Ovarian Cancer Susceptibility: A Regional Trial. Genetic Testing. 2(4). 305–313. 15 indexed citations
11.
Rowley, Peter T., Starlene Loader, & Jeffrey C. Levenkron. (1997). Cystic Fibrosis Carrier Population Screening: A Review. Genetic Testing. 1(1). 53–59. 12 indexed citations
12.
Robinson, R. D., et al.. (1994). Textural differences between AA and SS blood specimens as detected by image analysis. Cytometry. 17(2). 167–172. 8 indexed citations
13.
Rowley, Peter T., et al.. (1992). Induction of the FMS proto-oncogene product in HL-60 cells by vitamin D: A flow cytometric analysis. Leukemia Research. 16(4). 403–410. 7 indexed citations
14.
Skuse, Gary R., Barbara A. Kosciolek, & Peter T. Rowley. (1989). Molecular genetic analysis of tumors in von recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17. Genes Chromosomes and Cancer. 1(1). 36–41. 96 indexed citations
15.
Rowley, Peter T.. (1986). Psychological aspects of genetic counseling. The American Journal of Human Genetics. 38(1). 99–100. 4 indexed citations
16.
Warren, Nancy Steinberg, et al.. (1982). Newborn screening for hemoglobinopathies in New York State: Experience of physicians and parents of affected children. The Journal of Pediatrics. 100(3). 373–377. 26 indexed citations
17.
Rowley, Peter T.. (1980). Cellular and molecular regulation of hemoglobin switching. The American Journal of Human Genetics. 32(2). 288–290. 168 indexed citations
18.
Rowley, Peter T., et al.. (1974). Serum &alpha;<sub>1</sub>-Antitrypsin Types: Elastase Inhibition Versus Trypsin Inhibition. Human Heredity. 24(5-6). 472–481. 7 indexed citations
19.
Lipkin, Mack, et al.. (1974). Genetic responsibility: on choosing our children's genes. Plenum Press eBooks. 7 indexed citations
20.
Rowley, Peter T. & Dagmar Oette. (1973). Characteristics of the antitrypsin activity of human serum. Journal of Clinical Pathology. 26(1). 48–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walter W. Noll Breakdown of academic impact, for papers by Jan Waldenström Breakdown of academic impact, for papers by E.B. Robson Breakdown of academic impact, for papers by Janet van Adelsberg Breakdown of academic impact, for papers by C Borrone Breakdown of academic impact, for papers by Kenneth S. Zuckerman Breakdown of academic impact, for papers by Gábor Kovács Breakdown of academic impact, for papers by Ishwar C. Verma Breakdown of academic impact, for papers by Takeshi Taketani Breakdown of academic impact, for papers by Sara Rollinson
Rankless by CCL
2026